期刊文献+

N-乙酰半胱氨酸对急慢性吸烟大鼠肺组织和肺泡灌洗液中核因子-κB表达的影响 被引量:4

Effect of N-acetylcysteine on NF-κB in lung tissue and BALF of rats undergoing acute and chronic smoking
暂未订购
导出
摘要 目的 探讨抗氧化剂N 乙酰半胱氨酸 (NAC)对急慢性吸烟大鼠肺组织和肺泡灌洗液 (BALF)中核因子 κB (NF κB)表达的影响及机理。方法 将Wistar大鼠随机分成 :对照组 6只 ,吸烟组 30只 ,干预 (吸烟 +NAC)组 30只。其中吸烟组和干预组中动物均动态观察 1、 2、 7、 14、 6 0d (各时间点 6只 )的肺组织和BALF细胞中NF κB的激活水平。运用Western Blot免疫印迹电泳法 ,以抗NF κB抗体P5 0、P6 5作探针检测NF κB蛋白的表达量。结果 急慢性吸烟大鼠肺组织和BALF细胞中NF κB的表达以急性吸烟早期d 1、2达最高 ,肺组织在d 1、2的NF κB活性分别为 36 .9± 8.1和36 .9± 8.0 ,与对照组 7.3± 2 .8比较 ,均有显著性的差异 (P <0 .0 1) ;在d 1、2 ,BALF细胞的NF κB活性分别为 2 4 .0± 6 .1和 2 1.2± 5 .8,与对照组 5 .7±2 .6比较 ,也均有显著性的差异 (P <0 .0 1)。但吸烟7d ,NF κB的表达已有下降 ,并发现从急性吸烟 7、14d至慢性吸烟 6 0d ,NF κB维持在比较稳定的低水平表达 ,与对照组相比均无显著差异 (P >0 .0 5 )。NAC对被激活的NF κB有明显的抑制作用 ,与各自吸烟组相比P <0 .0 1,而对低水平NF κB表达的抑制作用不明显。结论 NAC通过抑制急性吸烟早期被激活的NF κB 。 Aim To assess the effect and mechanism of N acetylcysteine (NAC, antioxidant) on nuclear factor κB (NF κB) in lung tissue and bronhial alveolar lavage fluid(BALF) of rats undergoing acute and chronic smoking. Methods All Wistar rats were divided randomly into three groups: control group, smoking group and intervention group. The latter two groups were applied to observing NF κB expression during different periods (1, 2, 7, 14, 60d). Western Blot assay was used to analyze the activation of NF κB. Results The first and second day the expression of NF κB in lung tissue ( 36.9 ± 8.1 and 36.9 ± 8.0 )and in BALF( 24.0 ± 6.1 and 21.2 ± 5.8 ) rose significantly comparing with that in the control groups ( 7.3 ± 2.8 and 5.7 ± 2.6 )respectively (P< 0.01 ), but fell to the normal range of control at the seventh, fourteenth and sixtith days of smoking. NAC significantly inhibited the higher NF κB expression comparing with that in the related control smoking groups, but not inhibited the normal NF κB expression in the rest groups. Conclusion NAC, through inhibiting activation of NF κB during the early smoking stage and further blocking the activation of pro inflammatory cytokines, may play a role in pathogenesis of airway inflammation of COPD.
出处 《中国临床药理学与治疗学》 CAS CSCD 2001年第2期103-106,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 N-乙酰半胱氨酸 核因子-КB 吸烟 大鼠 肺组织 肺泡灌洗液 N acetylcysteine nuclear factor κB smoking rats
  • 相关文献

参考文献8

  • 1Repine JE, Bast A, Lankhorst I, et al. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med,1997; 156: 340
  • 2Lentsch AB, Cxermark BJ, Bless NM, et al. NF-κB activation during IgG immune complex induced lung injury: requirements for TNF-α and IL-β( but not complement. Am J Pathol,1998; 152: 1327
  • 3Blackwell TS, Blackwell TR, Holden EP, et al. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol, 1996; 57: 1630
  • 4Schreiber E, Matthias P, Muller MM, et al. Rapid detection of octamer binding proteins with ‘miniextracts', prepred from a small number of cells. Nucleic Acids Research, 1989; 17: 6419
  • 5Muller JM, Ziegler-Heitbrock HW, Baeuerle PA. Nuclear factor kappa B, a mediator of lipo-polysaccharide effects. Immunobiology,1993; 187: 233
  • 6Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad Res Comms, 1992; 17: 221
  • 7Nishikawa M, Kakemizu N, Takaaki I, et al. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-κB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Rspir Cell Mol Biol, 1999; 20: 189
  • 8Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol, 1997; 29: 867

同被引文献20

  • 1Stey C,Steurer J,Bachmann S,et al.The effect of oral N-acetylcysteine in chronic bronchitis.Eur Respir J,2001,16:253-262.
  • 2de Benedetto F,Aceto A,Dragani B,et al.Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD.Pulm Pharmacol Ther,2005,18:41-47.
  • 3Kasielski M,Nowak D.Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.Respir Med,2001,95:448-456.
  • 4de Backer WA,Amsel B,Jorens PG,et al.N-acetylcysteine pretreatment of cardiac surgery patient influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid.Intensive Care Med,1996,22:900-908.
  • 5Vignola AM,Riccobono L,Mirabella A,et al.Sputum metalloproteinase-9/tissue inhibitor of metalloproteinanse 21 ratio correlates with airflow obstruction in asthma and chronic bronchitis.Am J Respir Care Med,1998,158:1945-1950.
  • 6Rahman I,MacNee W.Oxidative stress and regulation of glutathione in lung inflammation.Eur Respir J,2000,16:534-554.
  • 7Zheng CH,Ahmed K,Rikitomi N,et al.The effects of S-carboxymethylcysteine and N-acetylcysteine on the adherence of Moraxella catarrhalis to human pharyngeal epithelial cells.Microbiol Immunol,1999,43:107-113.
  • 8Vecchiarelli A,Dottorini M,Pietrella D,et al.Macrophage activation by N-acetyl-cysteine in COPD patients.Chest,1994,105:806-811.
  • 9Riise GC,Larsson S,Larsson P,et al.The intrabronchial microbial flora in chronic bronchitis patients:a target for N-acetylcysteine therapy?.Eur Respir J,1994,7:94-101.
  • 10Poole PJ,Black PN.Oral mucolytic drugs for exacerbation of chronic obstructive pulmonary disease:systematic review.Br Med J,2001,322:1271-1274.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部